Abstract
Decidualization of the endometrial stromal cells (ESCs) is essential for successful embryo implantation. It involves the transformation of fibroblastic cells into epithelial-like cells that secrete cytokines, growth factors, and proteins necessary for implantation. Previous studies have revealed altered expression of miR-375 in the endometrium of patients with recurrent implantation failure and the ectopic stromal cells of patients with endometriosis. However, the exact molecular mechanisms, particularly the role of microRNAs (miRNAs) in the regulation of decidualization, remain elusive. In this study, we investigated whether decidualization is affected by miR-375 and its potential target(s). The findings demonstrated the downregulation of the expression of miR-375 in the secretory phase compared to its expression in the proliferative phase of the endometrium in normal donors. In contrast, it was upregulated in the secretory phase of the endometrium in infertility patients. Furthermore, during decidualization of ESCs in vitro, overexpression of miR-375 significantly reduced the transcript-level expression of forkhead box protein O1 (FOXO1), prolactin (PRL), and insulin-like growth factor binding protein-1 (IGFBP1), the well-known decidual cell markers. Overexpression of miR-375 also resulted in reduced decidualization-derived intracellular and mitochondrial reactive oxygen species (ROS) levels. Using the luciferase assay, we confirmed that NADPH oxidase 4 (NOX4) is a direct target of miR-375. Collectively, the study showed that the miR-375-mediated NOX4 downregulation reduced ROS production and attenuated the decidualization of ESCs. It provides evidence that miR-375 is a negative regulator of decidualization and could serve as a potential target for combating infertility.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Decidualization of the endometrium, the process of differentiation of human endometrial stromal cells (ESCs) during the menstrual cycle, occurs during more than 400 menstrual cycles in a woman’s lifetime. Endometrial stromal cells cause decidualization by inducing morphological and functional changes in the endometrium through increased intracellular cAMP levels after ovulation. This process is essential for successful implantation and, therefore, a successful pregnancy [1]. Decidualized human endometrial fibroblasts transform into secretory cells to produce phenotypic markers of decidual cells such as prolactin (PRL) and insulin-like growth factor binding protein-1 (IGFBP-1) [2, 3]. Reportedly, the impairment of this process is associated with a variety of pregnancy-related disorders and is a major cause of implantation failure and infertility [4].
MicroRNAs (miRNAs) are short (approximately 19–25 nucleotides in length) single-stranded non-coding RNA that regulate gene expression by post-transcriptional control of target genes. The activity of miRNAs is generally regulated by perfect or imperfect complementarity within the 3′-untranslated region (UTR) of the target mRNAs [5]. Aberrant miRNA expression has been shown to be associated with several diseases, including cancer, metabolic, and pregnancy-related disorders [6, 7]. Several studies have demonstrated the involvement of miRNAs in the regulation of decidualization. Qian et al. have reported that miR-222 is implicated in endometrial stromal cell differentiation [8], wherein Estella et al. have shown that MiR-96 and miR-135b decrease IGFBP-1 secretion by reducing forkhead box protein O1 (FOXO1) and homeobox A10 (HOXA10) expression in in vitro decidualization [9]. Furthermore, the expression of the members of the miR-200 family has been shown to be upregulated during the in vitro decidualization of ESCs, and aberrant expression of the members of the miR-200 family negatively affects decidualization [10]. MiR-375, located between the CRYBA2 and CCDC108 genes on human chromosome 1, plays a critical role in the biological function of the body [11]. miRNA microarray in the endometrium shows that miR-375 expression is upregulated during the window of implantation (WOI) in the endometrium of patients with recurrent implantation failure (RIF) [12]. In addition, dysregulation of miR-375 has been identified between ectopic and eutopic endometrium in endometriosis [13,14,15,16].
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX), a membrane-bound enzyme, is an important source of cellular reactive oxygen species (ROS), and the regulation of its activity is essential to maintain healthy ROS levels [17]. In the decidualization of ESCs, NOX mediates cyclic adenosine monophosphate (cAMP)-dependent decidualization [18]. Reportedly, NOX4 is highly expressed in the secretory phase compared to that in the proliferative phase of the endometrium [19], and its silencing inhibits the expression of PRL and IGFBP1 [18]. Although the integral role of NOX4 activation and ROS signaling in initiating the endometrial decidual transformation of human ESCs (HESCs) has been reported [18], the regulatory mechanisms of miR-375 related to endometrial decidualization have not been explored.
In this study, we aimed to investigate the correlation between miR-375 expression and decidualization in ESCs and inspect the importance of the miR-375-NOX4 axis in decidualization. The study demonstrates that the NOX4 involved in ROS production could be a direct target of miR-375.
Materials and Methods
Collection of Human Endometrial Tissue
Endometrial samples were collected during the proliferative or secretory phase of the menstrual cycle from participants at the Konyang university hospital. Samples representing infertility were collected from participants at the MizMedi hospital. The menstrual stage of the endometrial samples and samples with pathology suggesting endometrial diseases were confirmed by an experienced gynecological pathologist. The volunteer had self-reported regular, normal (21–35 days) menstrual cycles. The proliferative phase samples were collected at 9–11 menstrual cycle days (mcd), and the secretory phase samples were collected at 20–24 mcd in the mid-secretory phase. Moreover, the infertility samples were collected at 20–22 mcd in the mid-secretory phase from patients of normal menstrual cycles (21–42 days) (Table 1). None of the infertility patients were undergoing hormone therapy during sample collection.
This study was approved by the Bioethics Committee of Konyang University Hospital (IRB file No. KYUH 2018–11-007) and MizMedi hospital (IRB file No. MMIRB 2018–3). The participants signed informed consent.
Cell Culture, In Vitro Decidualization, and Cell Transfection
Immortalized non-neoplastic human endometrial stromal cells (T HESCs) were cultured in the DMEM/F-12 medium without phenol red (Sigma, USA), supplemented with 10% fetal bovine serum (FBS; GIBCO, USA), 1% insulin transferrin selenium (ITS) + Premix (Corning 3454352, USA), and 500 ng/mL puromycin (InvivoGen, USA). Cells were maintained at 37 ℃ in a humidified atmosphere with 5% CO2.
For in vitro decidualization, T HESCs were maintained for 6 days in the DMEM/F-12 medium containing 1 μM medroxyprogesterone 17-acetate (MPA; Sigma) and 0.5 mM 8-bromo-cyclic adenosine monophosphate (8-bromo-cAMP; Sigma), 2% FBS, and 1% ITS + Premix. The culture medium was replaced with a fresh medium every 2 days.
NOX4 siRNA, the miR-375 mimic, and the miR-375 inhibitor were transfected using Lipofectamine RNAiMAX (Thermo Fisher Scientific, USA) into T HESCs, following the manufacturer’s recommended protocol.
RNA Isolation and Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) Analysis
Total RNA was isolated from T HESCs or endometrial tissue biopsies using TRIzol® reagent (Ambion, Thermo Fisher Scientific) according to the manufacturer’s instructions. To investigate the mRNA expression, cDNA was synthesized from total RNA using Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase (Promega, USA). Quantitative real-time PCR was performed using iQ SYBR Green Supermix (BioRad) for the IGFBP1, PRL, FOXO1, NOX4, and GAPDH genes using a CFX 96 qPCR (BioRad Laboratories, USA). The primers used for real-time PCR are listed in Supplementary Table 1. The following PCR amplification conditions were used: an initial denaturation step at 95 ℃ for 3 m followed by 40 cycles of denaturation at 95 ℃ for 10 s, annealing for 10 s using suitable primer sets, and extension at 72 ℃ for 10 s.
To determine the relative miR-375 expression, cDNA was synthesized using the TaqMan miRNA Reverse transcription kit (Thermo Fisher Scientific, USA), with a reverse transcription miR-375 or RNU6B primer (Thermo Fisher Scientific, USA), according to the manufacturer’s instructions. Then quantitative real-time PCR was performed using TaqMan Master Mix II and TaqMan miRNA assay primer (Thermo Fisher Scientific, USA). The 2−ΔΔct method was used to calculate mRNA or miRNA expression levels using the reference gene.
Western Blotting
The T HESCs were lysed using lysis buffer (Jubiotech, Korea) containing protease and phosphatase inhibitor (Roche, Swiss). The protein concentrations were measured using the bicinchoninic acid (BCA) assay (Thermo Fisher Scientific). Proteins in cell lysate were resolved by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA). The blots were then blocked with 5% skim milk (Difco, USA) and probed overnight with primary antibodies at 4 ℃. The primary antibodies used in this study included FOXO1 (1:1000, cell signaling, #2880), NOX4 (1:1000, Abcam, ab109225), and GAPDH (1:5000, cell signaling, #5174). After probing with primary antibodies, the membrane was incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibodies (1:5000, Millipore, AP132P). The expression of the target proteins was determined using an enhanced chemiluminescence kit (Thermo Fisher Scientific).
Enzyme-Linked Immunosorbent assay (ELISA)
The conditioned media were collected after stimulation for decidualization of T HESCs. The IGFBP1 and PRL levels were measured using the manufacturer’s instructions provided along with the ELISA kit (R&D Systems, USA). The optical density was read using a BioTek microplate reader (BioTek instrument, USA).
Plasmid Construction and Luciferase Reporter Assay
To investigate whether miR-375 modulates NOX4 expression by binding to its 3´UTR, the NOX4 3´UTR was amplified using a forward primer containing an XhoI restriction site (5´-CCA CTC GAG TGC CAT GAA GCA GGA CTC TA-3´), and a reverse primer containing a NotI restriction site (5´-CCA GCG GCC GCC AGA GTC TTG TGC TGT GTT TTC A-3´). The NOX4 3´UTR region was cloned into the dual-luciferase psiCHECK2 vector (Promega, Madison, WI). Mutagenesis of the binding site of miR-375 was accomplished using the KOD Plus Mutagenesis kit (Toyobo, Osaka, Japan). The sequence of the cloned vectors was verified using DNA sequencing. The cloned vector and the miR-375 mimic were co-transfected into T HESCs using the Lipofectamine 3000 (Thermo Fisher Scientific). Then, the transfected T HESCs were cultured. Afterward, luciferase activity in the transfected cells was measured using the dual-luciferase reporter assay system following the Promega instruction manual (Promega, USA). Luminescent activities of firefly luciferase were used as the internal control for the normalization of transfection efficiency. Luciferase assays were performed in triplicate.
Measurement of ROS
To measure the intracellular ROS levels, T HESCs were seeded into the plate and incubated after stimulation with 0.5 mM 8-bromo-cAMP and 1 μM MPA for decidualization. After harvesting the cells, the cells were treated with 25 μM 2´,7´-dichlorodihydrofluorescein diacetate (DCF-DA) for 15 min in the dark at 37 ℃. We estimated the oxidation of the dye by measuring 10,000 events per sample using flow cytometry (FACS, Beckman).
To measure the mitochondrial ROS levels, T HESCs were cultured for decidualization, with 0.5 mM 8-bromo-cAMP and 1 μM MPA, and incubated with 5 μM Mitosox™ Red (Thermo Fisher Scientific) for 10 min in the dark at 37 ℃. The cells were visualized using confocal microscopy (Carl Zeiss, Germany), and the fluorescence intensity was determined using ImageJ (http://imagej.nih.gov.ij).
Statistical Analyses
The data are presented as the mean ± standard error of the mean (SEM). All experiments were performed in triplicate. The results were analyzed using Student’s t test or Mann–Whitney test. Results were considered statistically significant at P < 0.05 or P < 0.01.
Results
Inverse Relationship of miR-375 with Decidualization
The microarray-based miRNA profiling studies have shown that miR-375 is upregulated during the WOI in the endometrium of RIF patients [12]. Therefore, we investigated the change in miR-375 expression between the proliferative and secretory phases of the endometrium to find a link to decidualization. In the normal endometrial tissue biopsy samples, the quantitative RT-PCR revealed downregulation of the expression of miR-375 in the secretory phase samples compared with that in the proliferative phase samples. On the contrary, its expression was upregulated in the secretory phase samples collected from the endometrial biopsies of the patients with infertility (Fig. 1a). Further decidualization of T HESCs in vitro by treating T HESCs with cAMP and MPA demonstrated significant downregulation of the expression of miR-375 in the decidualized T HESCs (Fig. 1b). In addition, the significant upregulation of decidual markers, including FOXO1, PRL, and IGFBP1, confirmed the decidualization status of T HESCs (Fig. 1c–e). These results revealing an inverse relationship between miR-375 expression and decidualization indicate that the suppression of expression of miR-375 is essential for decidualization.
Inhibition of T HESCs Decidualization Through miR-375 Overexpression
To confirm the role of mir-375 on decidualization, the effect of miR-375 overexpression on the mRNA and protein expression of the decidual markers, FOXO1, PRL, and IGFBP-1 was investigated. The findings demonstrated that overexpression of miR-375 significantly reduced the transcript-level expression of FOXO1, PRL, and IGFBP1 in decidual cells than that of the negative control (Fig. 2a–c). miR-375 overexpression also inhibited the expression of FOXO1 protein significantly (Fig. 2d). Further, estimation of the effects of mir-375 overexpression on the secretion of PRL and IGFBP1 in the decidualized cells using ELISA revealed a significant reduction of the expression these two marker proteins in T HESCs transfected with miR-375 mimic (Fig. 2e, f). These results indicate that miR-375 overexpression suppresses the decidualization of ESCs.
Inhibition of ROS Production by miR-375 During In Vitro Decidualization in T HESCs
As the resistance to oxidative stress and the levels of intracellular ROS remarkably increase during decidualization of ESCs [20, 21], we analyzed the intracellular and mitochondrial ROS levels in decidualized T HESCs in vitro. DCFDA oxidation levels were significantly higher in decidualized T HESCs stimulated with 8-br-cAMP and MPA (decidualized) than in those grown in the absence of 8-br-cAMP and MPA (control) (Fig. 3a). The level of mitochondrial ROS was also higher in the decidualized condition than in the control condition (Fig. 3b).
Furthermore, the overexpression of miR-375 in T HESCs stimulated with 8-br-cAMP and MPA exhibited reduced intracellular (P < 0.05) and mitochondrial (P < 0.01) ROS production (Fig. 3c, d) than in those grown without 8-br-cAMP and MPA. These results suggest that the target gene of miR-375 could be associated with ROS production.
NOX4: a Direct Target of miR-375
Next, to identify a direct target of miR-375 associated with ROS production, we searched the miRDB database, an online database for miRNA target prediction and functional annotations (http://www.mirdb.org). The search identified 269 genes targeted by miR-375, including the NOX4 gene. Reportedly, NOX4 plays an important role in regulating the levels of intracellular ROS and changes in the expression of decidual markers PRL and IGFBP-1 in HESCs [18]. Therefore, we selected NOX4 for further analyses. Two binding sites were predicted for miR-375 between nt 2226 and 2254 in the 3′UTR of NOX4 mRNA (NM_016931; Fig. 4a). To confirm the direct interaction between miR-375 and NOX4, we performed a dual-luciferase reporter assay with the 3´UTR of NOX4 in T HESCs. The overexpression of miR-375 significantly inhibited the luciferase activity of the mutant at the first binding site, whereas the reduction in luciferase activity of the mutant at the second binding site was non-significant. Moreover, when the reporter at the two binding sites of miR-375 was mutated, no change in luciferase activity was observed. Therefore, we suggest that miR-375 binds onto the second binding site of NOX4 3´UTR (Fig. 4b). Further, the qRT-PCR and western blotting analyses demonstrated that NOX4 mRNA and protein expression were significantly reduced by miR-375 overexpression (Fig. 4c, d). In contrast, inhibition of miR-375 significantly increased the mRNA expression of NOX4 in T HESCs (Fig. 4e). These results indicate the crucial role of mir-375 in regulating NOX4 expression.
Significance of NOX4 for T HESCs Decidualization
We have shown that in normal endometrial biopsies, the expression of miR-375 was decreased in the secretory phase than in the proliferative phase of the endometrium (Fig. 1a). Therefore, to unravel the relationship between the expression of NOX4 and decidualization, we analyzed the difference in the expression of NOX4 between the proliferative and secretory phases of the endometrium. NOX4 expression was significantly increased in the secretory phase compared to that in the proliferative phase of the endometrium. Moreover, NOX4 expression was downregulated in the secretory phase of endometrium in the samples collected from patients with infertility (although not significantly compared to normal secretory phase) (Fig. 5a). The expression of NOX4 in the proliferative phase of the endometrium showed an inverse pattern with respect to miR-375 expression (Figs. 1a and 5c). The mRNA and protein expression of NOX4 were significantly increased in T HESCs after in vitro cAMP- and MPA-induced decidualization (Fig. 5b, c). Furthermore, NOX4 knockdown in T HESCs attenuated the expression of decidual markers FOXO1, PRL, and IGFBP-1 (Fig. 5d–f). NOX4 knockdown also reduced intracellular and mitochondrial ROS levels during in vitro decidualization (Fig. 5h, i). Collectively, these results suggested that miR-375-mediated expression changes in NOX4 could be related to the decidualization of ESCs.
Discussion
The uterine ESCs transform into decidual cells during decidualization, which is critical for establishing and maintaining pregnancy, as aberrant decidualization leads to pregnancy loss [22]. Several studies have reported the differential expression of several miRNAs before and after human endometrial stromal decidualization [8, 9, 23]. In addition, it has also been reported that normal ESCs and endometriotic cyst stromal cells are regulated by different mechanisms of miRNA [24], suggesting that miRNAs play important roles in human endometrial stromal decidualization. To the best of our knowledge, we are the first to provide evidence for the crucial role of miR-375 in endometrial decidualization. We demonstrate that the upregulation of miR-375 in HESCs suppresses the decidualization of these cells in vitro and confirm that NOX4 is a direct target of miR-375.
Previous studies have reported that miR-375 plays an important role in the formation of pancreatic beta-cells [25]. The progesterone receptor (PGR) has been identified as a direct target of miR-375 in the endometrium of rhesus monkeys [26]. Rekker et al. reported aberrant miR-375 expression in ectopic stromal cells of an endometriosis patient [16]. Similarly, other miRNAs have also been reported to be involved in decidualization. miR-181a regulates the decidualization of ESCs by targeting the Kruppel-like factor 12 (KLF12) [27], while miR-542-mediated IGFBP-1 downregulation is associated with decidualization [28]. miR-194-3p has also been reported to have a relationship with decidualization via the downregulation of PGR [29]. Recently, Qu et al. have reported that miR-542-3p inhibits decidualization through the downregulation of the ILK pathway [30]. In our study, miR-375 was found to be a negative regulator of decidualization in HESCs.
During the transformation of ESCs from their normal state into a decidualized state, the decidual stromal cells generate ROS and resist cellular stress signals, to maintain the feto-maternal interface [31]. Cu, Zn-superoxide dismutase (SODs), and mitochondrial Mn-SOD are specific enzymes that scavenge superoxide radicals, the major form of ROS, and are generated after differentiation of the ESCs [32, 33]. Decidualization of ESCs also increases resistance to hydrogen peroxide-induced oxidative stress [20]. Decidual stromal cells differentiated from ESCs transform into protein-secreting cells and induce endoplasmic reticulum (ER) stress by accumulating misfolded proteins to activate secretory pathways in the ER. Consequently, ER stress induces ROS, which is involved in decidualization [34]. In addition, ESCs subjected to decidualization stimuli, such as 8-br-cAMP, MPA, and PGE2, show markedly elevated ROS levels [21]. Recently, resveratrol, well known as an antioxidant and anti-inflammatory agent, has been shown to inhibit decidualization through the downregulation of decidual markers [35]. In addition, oxidative stress increased FOXO1 expression via JNK in follicular granulosa cells in mice [36, 37]. FOXO1 has been reported to be an important factor in the decidualization of HESCs, and FOXO1 knockdown attenuates IGFBP-1 and PRL expression, the well-known decidual markers [38]. The NOX family enzymes are considered the major ROS producers in cells. Inhibition of NOX attenuates cAMP-dependent decidualization, and the silencing of NOX4 (among the NOX family members) inhibits the expression of IGFBP1 and PRL [18]. Degasper et al. have also suggested that NOX4 may play an important role in secretory transformation because it exhibits significantly higher expression in the secretory phase than in the proliferative phase of the endometrium [19]. In this study, we demonstrated that miR-375 downregulates NOX4 expression, and the downregulated NOX4 attenuates ROS production in ESCs. Taken together, we inferred that upregulation of miR-375 and downregulation of NOX4 in the endometrium inhibit decidualization leading to infertility and thereby suggest that miR-375/NOX4 axis plays an important role in pregnancy and could be a potential target for combating infertility. However, further investigations are required to ascertain the physiological and clinical relevance of the miR-375/NOX4 axis in infertility.
There are some limitations to this study. The sample of the same menstrual stage was small in size. The sample needs more refined timing across the menstrual cycle. However, more time is needed for refined timing sample collection, and it is very difficult to obtain sufficient endometrium samples for research owing to ethical restrictions. We are currently collecting endometrium samples to unravel the pathways and interactions of the miR-375/NOX4 axis with other critical mechanisms in decidualization to determine their precise relevance to combat infertility.
Conclusion
This study, for the first time, offers evidence that miR-375 binds directly to the 3′UTR of NOX4 in ESCs, and the miR-375-mediated NOX4 downregulation reduces ROS production, which consequently attenuates the decidualization of ESCs. These results confirmed that miR-375 acts as a negative regulator of decidualization and could be a potential target for combating infertility.
Availability of Data and Material
All data generated or analyzed during this study are included in this published article and its supplementary information files.
Code Availability
Not applicable.
References
Gellersen B, Brosens IA, Brosens JJ. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med. 2007;25(6):445–53.
Telgmann R, Gellersen B. Marker genes of decidualization: activation of the decidual prolactin gene. Hum Reprod Update. 1998;4(5):472–9.
Fowler DJ, Nicolaides KH, Miell JP. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum Reprod Update. 2000;6(5):495–504.
Salker M, Teklenburg G, Molokhia M, Lavery S, Trew G, Aojanepong T, Mardon HJ, Lokugamage AU, Rai R, Landles C, Roelen BAJ, Quenby S, Kuijk EW, Kavelaars A, Heijnen CJ, Regan L, Macklon NS, Brosens JJ. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One. 2010;5(4):e10287.
Cannell IG, Kong YW, Bushell M. How do microRNAs regulate gene expression? Biochem Soc Trans. 2008;36(Pt 6):1224–31.
Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–22.
Cai M, Kolluru GK, Ahmed A. Small molecule, big prospects: MicroRNA in pregnancy and its complications. J Pregnancy. 2017;2017:6972732.
Qian K, Hu L, Chen H, Li H, Liu N, Li Y, Ai J, Zhu G, Tang Z, Zhang H. Hsa-miR-222 is involved in differentiation of endometrial stromal cells in vitro. Endocrinology. 2009;150(10):4734–43.
Estella C, Herrer I, Moreno-Moya JM, Quinonero A, Martinez S, Pellicer A, Simon C. miRNA signature and dicer requirement during human endometrial stromal decidualization in vitro. PLoS One. 2012;7(7):e41080.
Jimenez PT, Mainigi MA, Word RA, Kraus WL, Mendelson CR. miR-200 regulates endometrial development during early pregnancy. Mol Endocrinol. 2016;30(9):977–87.
Keller DM, McWeeney S, Arsenlis A, Drouin J, Wright CV, Wang H, Wollheim CB, White P, Kaestner KH, Goodman RH. Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem. 2007;282(44):32084–92.
Shi C, Shen H, Fan LJ, Guan J, Zheng XB, Chen X, Liang R, Zhang XW, Cui QH, Sun KK, Zhao Z-R, Han H-J. Endometrial microRNA signature during the window of implantation changed in patients with repeated implantation failure. Chin Med J. 2017;130(5):566–73.
Filigheddu N, Gregnanin I, Porporato PE, Surico D, Perego B, Galli L, Patrignani C, Graziani A, Surico N. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol. 2010;2010:369549.
Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, Matzuk MM. Functional microRNA involved in endometriosis. Mol Endocrinol. 2011;25(5):821–32.
Logan PC, Yango P, Tran ND. Endometrial stromal and epithelial cells exhibit unique aberrant molecular defects in patients with endometriosis. Reprod Sci. 2018;25(1):140–59.
Rekker K, Tasa T, Saare M, Samuel K, Kadastik U, Karro H, Gotte M, Salumets A, Peters M. Differentially-expressed miRNAs in ectopic stromal cells contribute to endometriosis development: The plausible role of miR-139-5p and miR-375. Int J Mol Sci. 2018;19(12):3789.
Brandes RP, Weissmann N, Schroder K. Nox family NADPH oxidases: molecular mechanisms of activation. Free Radic Biol Med. 2014;76:208–26.
Al-Sabbagh M, Fusi L, Higham J, Lee Y, Lei K, Hanyaloglu AC, Lam EW, Christian M, Brosens JJ. NADPH oxidase-derived reactive oxygen species mediate decidualization of human endometrial stromal cells in response to cyclic AMP signaling. Endocrinology. 2011;152(2):730–40.
Degasper C, Brunner A, Sampson N, Tsibulak I, Wieser V, Welponer H, Marth C, Fiegl H, Zeimet AG. NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer. Tumour Biol. 2019;41(2):1010428319830002.
Kajihara T, Jones M, Fusi L, Takano M, Feroze-Zaidi F, Pirianov G, Mehmet H, Ishihara O, Higham JM, Lam EW, Brosens JJ. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization. Mol Endocrinol. 2006;20(10):2444–55.
Erkenbrack EM, Maziarz JD, Griffith OW, Liang C, Chavan AR, Nnamani MC, Wagner GP. The mammalian decidual cell evolved from a cellular stress response. PLoS Biol. 2018;16(8):e2005594.
Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev. 2014;35(6):851–905.
Wang Y, Lv Y, Gao S, Zhang Y, Sun J, Gong C, Chen X, Li G. MicroRNA profiles in spontaneous decidualized menstrual endometrium and early pregnancy decidua with successfully implanted embryos. PLoS One. 2016;11(1):e0143116.
Aoyagi Y, Nasu K, Kai K, Hirakawa T, Okamoto M, Kawano Y, Abe W, Tsukamoto Y, Moriyama M, Narahara H. Decidualization differentially regulates microRNA expression in eutopic and ectopic endometrial stromal cells. Reprod Sci. 2017;24(3):445–55.
Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol. 2007;5(8):e203.
Liu JL, Liang XH, Su RW, Lei W, Jia B, Feng XH, Li ZX, Yang ZM. Combined analysis of microRNome and 3’-UTRome reveals a species-specific regulation of progesterone receptor expression in the endometrium of rhesus monkey. J Biol Chem. 2012;287(17):13899–910.
Zhang Q, Zhang H, Jiang Y, Xue B, Diao Z, Ding L, Zhen X, Sun H, Yan G, Hu Y. MicroRNA-181a is involved in the regulation of human endometrial stromal cell decidualization by inhibiting Kruppel-like factor 12. Reprod Biol Endocrinol. 2015;13:23.
Tochigi H, Kajihara T, Mizuno Y, Mizuno Y, Tamaru S, Kamei Y, Okazaki Y, Brosens JJ, Ishihara O. Loss of miR-542-3p enhances IGFBP-1 expression in decidualizing human endometrial stromal cells. Sci Rep. 2017;7:40001.
Pei T, Liu C, Liu T, Xiao L, Luo B, Tan J, Li X, Zhou G, Duan C, Huang W. miR-194-3p Represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis. Endocrinology. 2018;159(7):2554–62.
Qu X, Fang Y, Zhuang S, Zhang Y. Micro-RNA miR-542-3p suppresses decidualization by targeting ILK pathways in human endometrial stromal cells. Sci Rep. 2021;11(1):7186.
Ng SW, Norwitz GA, Pavlicev M, Tilburgs T, Simon C, Norwitz ER. Endometrial decidualization: the primary driver of pregnancy health. Int J Mol Sci. 2020;21(11):4092.
Sugino N, Shimamura K, Takiguchi S, Tamura H, Ono M, Nakata M, Nakamura Y, Ogino K, Uda T, Kato H. Changes in activity of superoxide dismutase in the human endometrium throughout the menstrual cycle and in early pregnancy. Hum Reprod. 1996;11(5):1073–8.
Sugino N, Kashida S, Takiguchi S, Nakamura Y, Kato H. Induction of superoxide dismutase by decidualization in human endometrial stromal cells. Mol Hum Reprod. 2000;6(2):178–84.
Yang Y, Pei X, Jin Y, Wang Y, Zhang C. The roles of endoplasmic reticulum stress response in female mammalian reproduction. Cell Tissue Res. 2016;363(3):589–97.
Ochiai A, Kuroda K, Ozaki R, Ikemoto Y, Murakami K, Muter J, Matsumoto A, Itakura A, Brosens JJ, Takeda S. Resveratrol inhibits decidualization by accelerating downregulation of the CRABP2-RAR pathway in differentiating human endometrial stromal cells. Cell Death Dis. 2019;10(4):276.
Shen M, Lin F, Zhang J, Tang Y, Chen WK, Liu H. Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress. J Biol Chem. 2012;287(31):25727–40.
Weng Q, Liu Z, Li B, Liu K, Wu W, Liu H. Oxidative Stress Induces Mouse Follicular Granulosa Cells Apoptosis via JNK/FoxO1 Pathway. PLoS One. 2016;11(12):e0167869.
Takano M, Lu Z, Goto T, Fusi L, Higham J, Francis J, Withey A, Hardt J, Cloke B, Stavropoulou AV, Ishihara O, Lam EW, Unterman TG, Brosens JJ, Kimet JJ. Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. Mol Endocrinol. 2007;21(10):2334–49.
Funding
This research was supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, grant number NRF-2017R1A6A1A03015713.
Author information
Authors and Affiliations
Contributions
Study design: SLY, JKJ, SRP. Data analysis: SLY, DUJ, YK, THK, ARH. Construction of figures: SLY, DUJ, YK. Manuscript preparation: SLY, JKJ, SRP. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
This study was approved by the Bioethics Committee of the Konyang University Hospital (Institutional Review Board File No. KYUH 2018‑11‑007) and MizMedi (Institutional Review Board File No.MMIRB2018-3).
Consent to Participate
All patients provided written informed consent.
Consent for Publication
All authors of this article are responsible for their contributions and agree to publish this article in this journal.
Conflict of Interest
The authors declare no competing interests.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yu, SL., Jeong, DU., Kang, Y. et al. Impairment of Decidualization of Endometrial Stromal Cells by hsa-miR-375 Through NOX4 Targeting. Reprod. Sci. 29, 3212–3221 (2022). https://doi.org/10.1007/s43032-022-00854-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-022-00854-w